a preferred embodiment according to the present invention will now be discussed . in the preferred embodiment , ivomec ( registered trademark of merial ltd .) injection , which is used as an anti - parasite preparation , was used as an ivermectin preparation . the preparation includes 10 mg of ivermectin in 1 ml . aleviatin ( registered trademark of dainippon pharmaceutical co ., ltd .) injection liquid , which was used as an anticonvulsant , was used as a phenytoin preparation . the preparation includes 50 mg of phenytoin in 1 ml . the solubility of ivomec injection and aleviatin injection liquid relative to water and 70 percent ethyl alcohol solution was as shown in the following table . prescription 1 ivomec injection 33 . 33 volume percent 70 percent ethyl alcohol solution 66 . 66 volume percent prescription 2 aleviatin injection liguid 33 . 33 volume percent 70 percent ethyl alcohol solution 66 . 66 volume percent prescription 3 ivomec injection 22 . 22 volume percent aleviatin injection liquid 11 . 11 volume percent 70 percent ethyl alcohol solution 66 . 66 volume percent in the following examples , the prescriptions were all directly injected to the lesion . however , the prescriptions may also be injected to the artery that supplies the lesion with blood . prescription 1 was locally injected to treat anus tumor in a large - size dog ( male , weighing about 17 kg ). an amount of 1 . 0 cc per injection was administered once a month for a total of six times . the observations were as shown in table 4 . prescription 1 was locally injected to treat mastadenoma and melanoma in a medium - size dog ( female , weighing about 13 kg ). an amount of 1 . 0 cc per injection was administered once a month for a total of three times to the mastadenoma . an amount of 1 . 0 cc per injection was administered once to the melanoma . the observations were as shown in table 4 . prescription 1 was locally injected to treat vaginal sarcoma in a medium - size dog ( female , weighing about 10 . 5 kg ). a total of 0 . 9 cc , 0 . 3 cc for each of three locations in the sarcoma , was injected and administered once a month for a total of two times . the observations were as shown in table 4 . prescription 1 was locally injected to treat mastocytoma formed near the groin at the right rear leg in a large - size dog ( male , weighing about 22 kg ). an amount of 1 . 0 cc per injection was administered once a month for a total of two times . the observations were as shown in table 4 . prescription 1 was locally injected to treat malignant skin histoma formed near the outer side of the left hip in a small - size dog ( female , weighing about 4 kg ). an amount of 0 . 2 cc per injection was administered once a month for a total of two times . the observations were as shown in table 4 . prescription 1 was locally injected to treat subcutaneous lymphoma formed in the back of a small - size dog ( female , weighing about 3 kg ). an amount of 0 . 2 cc was injected and administered once a month for a total of two times . the observations were as shown in table 4 . prescription 2 was locally injected to treat mastadenoma formed in the left and right mammary glands of a small - size dog ( male , weighing about 5 kg ). since tumors were confirmed at ten locations , instead of administering all of the prescription at one location , the prescription was injected at three locations for each administration . the injections were administered sequentially in a cyclic manner to cover every location . a total of 0 . 6 cc , 0 . 2 cc per tumor , was administered once a month for a total of ten times . the observations were as shown in table 4 . prescription 1 was locally injected to treat the right mammary gland for mastadenoma in a large - size dog ( female , weighing about 20 kg ). the prescription was injected at three locations of the sarcoma . an amount of 0 . 5 cc was injected at each of the three locations totaling to 1 . 5 cc per administration once a month for a total of two times . the observations were as shown in table 4 . prescription 3 was locally injected to treat multiple skin cancer and chondrosarcoma of the entire body and the 16th rib in a large - size dog ( male , weighing about 18 kg ). an amount of 1 . 0 cc per injection was administered once a month for a total of two times to treat the multiple skin cancer . an amount of 1 . 0 cc per injection was administered once a month for a total of three times to treat the chondrosarcoma . the observations were as shown in table 4 . prescription 1 was locally injected to treat osteosarcoma in the rear left femur of a medium - size dog ( male , weighing about 15 kg ). an amount of 1 . 0 cc per injection was administered once . the observations were as shown in table 4 . prescription 1 was locally injected to treat folliculus pili cellular tumor in the neck and left back - side hip of a large - size dog . an amount of 0 . 5 cc was injected to the sarcoma at one location and an amount of 0 . 7 cc was injected to the sarcoma at another location . a total of 1 . 5 cc was administered once a month for a total of two times . the observations were as shown in table 4 . prescription 1 was locally injected to treat upper jaw sinus sarcoma of the nasal cavity upper jaw sinus in a cat ( male , weighing about 3 kg ). an amount of 0 . 5 cc per injection was administered once a month for a total of three times . the observations were as shown in table 4 . prescription 1 was locally injected to treat lymphoma of the rear right groin in a small - size dog ( male , weighing about 5 kg ) once . the observations were as shown in table 4 .
a local injection prescription that disperses a malignant tumor to decrease the size of the tumor or terminate the tumor . the local injection prescription is produced by dissolving an organic compound having a lactone nucleus in lower alcohol and water .